![Johan Raud](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Johan Raud
Chief Tech/Sci/R&D Officer at VICORE PHARMA HOLDING AB
Johan Raud active positions
Companies | Position | Start | End |
---|---|---|---|
VICORE PHARMA HOLDING AB | Chief Tech/Sci/R&D Officer | 2017-12-31 | - |
Career history of Johan Raud
Former positions of Johan Raud
Companies | Position | Start | End |
---|---|---|---|
KI Management AB
![]() KI Management AB Investment ManagersFinance KI Management AB (KIM) is a venture capital investment firm located in Stockholm, on the campus of the Karolinska Institute. They are the investment advisor and manager of the Karolinska Investment Fund KB (KIF). The fund was established in 1999 by the Karolinska Institute and Alecta, a Nordic pension plan. KIM has a partnership agreement with Karolinska Innovations AB, a technology transfer entity of the Karolinska Institute. The Karolinska Institute, founded in 1810, has a medical focus and is responsible for selecting the winner of the Nobel Prize in Physiology or Medicine. | Private Equity Investor | 1999-12-31 | 2007-12-30 |
Independent Pharmaceutica AB
![]() Independent Pharmaceutica AB Medical DistributorsDistribution Services Independent Pharmaceutica AB is a privately owned company. The major owners are Karolinska Investment Fund, LH Advisory, Sandin &Co and The Foundation for Baltic and East European Studies (Östersjöstiftelsen). Independent Pharmaceutica aims to provide pharmacological solutions for treatment of nicotine addiction. The company is spun out of research from the Karolinska Institutet in Stockholm, Sweden. Tobacco use is the leading preventable cause of morbidity and premature death in the world.Currently over 1.2 billion people smoke worldwide and the number of annual deaths from tobacco-related diseases is over 4 million and rising. The costs for society are huge. With the new vaccine Niccine® against nicotine addiction, the health condition of millions of patients is expected to be improved. | Director/Board Member | - | - |
Training of Johan Raud
Karolinska Institutet | Doctorate Degree |
Vanderbilt University | Doctorate Degree |
Statistics
International
Sweden | 5 |
United States | 2 |
Operational
Doctorate Degree | 2 |
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sectoral
Consumer Services | 3 |
Finance | 2 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
VICORE PHARMA HOLDING AB | Health Technology |
Private companies | 2 |
---|---|
KI Management AB
![]() KI Management AB Investment ManagersFinance KI Management AB (KIM) is a venture capital investment firm located in Stockholm, on the campus of the Karolinska Institute. They are the investment advisor and manager of the Karolinska Investment Fund KB (KIF). The fund was established in 1999 by the Karolinska Institute and Alecta, a Nordic pension plan. KIM has a partnership agreement with Karolinska Innovations AB, a technology transfer entity of the Karolinska Institute. The Karolinska Institute, founded in 1810, has a medical focus and is responsible for selecting the winner of the Nobel Prize in Physiology or Medicine. | Finance |
Independent Pharmaceutica AB
![]() Independent Pharmaceutica AB Medical DistributorsDistribution Services Independent Pharmaceutica AB is a privately owned company. The major owners are Karolinska Investment Fund, LH Advisory, Sandin &Co and The Foundation for Baltic and East European Studies (Östersjöstiftelsen). Independent Pharmaceutica aims to provide pharmacological solutions for treatment of nicotine addiction. The company is spun out of research from the Karolinska Institutet in Stockholm, Sweden. Tobacco use is the leading preventable cause of morbidity and premature death in the world.Currently over 1.2 billion people smoke worldwide and the number of annual deaths from tobacco-related diseases is over 4 million and rising. The costs for society are huge. With the new vaccine Niccine® against nicotine addiction, the health condition of millions of patients is expected to be improved. | Distribution Services |
- Stock Market
- Insiders
- Johan Raud
- Experience